Rib-X Pharmaceuticals IPO Research Information

Rib-X Pharmaceuticals IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Rib-X Pharmaceuticals, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Rib-X Pharmaceuticals	RIBX - NASDAQ	$6.00-$7.00	$0.00	$0.00	10 million
Underwriter(s): Deutsche Bank Securities
Co-Manager(s): William Blair, Lazard Capital Markets, Needham & Co.
Industry:
Filing(s): Filed 2011-11-25

About Rib-X Pharmaceuticals (adapted from Rib-X Pharmaceuticals prospectus):
We are a biopharmaceutical company developing new antibiotics to provide superior coverage, safety and convenience for the treatment of serious and life-threatening infections.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "RIBX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.